نتایج جستجو برای: sickle cell thalassemia

تعداد نتایج: 1700470  

2009
Raffaella Mariani Paola Trombini Matteo Pozzi Alberto Piperno

THERE ARE TWO MAIN MECHANISMS BY WHICH IRON OVERLOAD DEVELOPS IN THALASSEMIAS: increased iron absorption due to ineffective erythropoiesis and blood transfusions. In nontransfused patients with severe thalassemia, abnormal dietary iron absorption increases body iron burden between 2 and 5 g per year. If regular transfusions are required, this doubles the rate of iron accumulation leading to ear...

Journal: :Transfusion 2013
Scott T Miller Hae-Young Kim Debra L Weiner Carrie G Wager Dianne Gallagher Lori A Styles Carlton D Dampier Susan D Roseff

BACKGROUND Transfusion of red blood cells (RBCs) is frequently required for care of individuals with sickle cell disease (SCD). Alloimmunization rates are high and may be reduced by matching for RBC antigens that can cause alloimmunization. STUDY DESIGN AND METHODS During the PROACTIVE Feasibility Study, patients with SCD age 2 years or older admitted for pain without acute chest syndrome wer...

Journal: :Haematologica 2005
Victor R Gordeuk

BACKGROUND AND OBJECTIVES During the last decade new approaches to the treatment of pulmonary arterial hypertension (PH) have increased symptomatic relief and prolonged survival. PH is a common sequel of the hemoglobinopathies, thalassemia and sickle cell anemia, but the use of standard oral treatment options, such as calcium channel blockers, endothelin receptor antagonists, and long-term anti...

Journal: :Blood 2003
Mohamed Bradai Mohand Tayeb Abad Serge Pissard Fatima Lamraoui Laurent Skopinski Mariane de Montalembert

Hydroxyurea (HU) enhances fetal hemoglobin (Hb) production. An increase in total Hb level has been repeatedly reported during HU treatment in patients with sickle cell disease and in several patients with beta-thalassemia intermedia. Effects in patients with beta-thalassemia major are controversial. We now report a marked elevation of total Hb levels with HU that permitted regular transfusions ...

Journal: :Hemoglobin 2008
Béatrice Gulbis Alice Ferster Christiane Vermylen Marie-Françoise Dresse Anna Vanderfaeillie André Delannoy Veerle Labarque Pierre Philippet Alain Kentos Bernard Sztern Bernard Deprijck Françoise Vertongen

An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium has been approached through a confidential inquiry sent to 228 pediatric and adult hematological departments. Forty-two percent of responses showed that 417 patients are known in Belgium: 83% with sickle cell disease, 13% with beta-thalassemia (beta-thal) major, 2% with beta-thal intermedia, and 1%...

2010

Hereditary hemolytic disorders are important public health challenges in India. They cause a high degree of morbidity, mortality and fetal wastage in vulnerable communities. Tradition-bound-psychosocial influences are detrimental to the process of prevention. This study was designed to create awareness, motivate, and sensitize two major vulnerable tribal communities: Bhuyan and Kharia for hemog...

2017
Geeta Mandhani Manas Kalra Ramani Narasimhan V K Khanna Amita Mahajan

INTRODUCTION Avascular necrosis of the head of femur (AVNF) has frequently been reported with sickle cell anemia but is not commonly associated with beta thalassemia. CASE REPORT We report a case of 14-year-old male with transfusion-dependent thalassemia (TDT) and hepatitis C, who developed bilateral atraumatic AVNF requiring surgical correction. The likely etiopathogenesis and the review of ...

2012
Nahid Ashjazadeh Sajad Emami Peyman Petramfar Ehsan Yaghoubi Mehran Karimi

Introduction. Patients with β-thalassemia intermedia have a higher incidence of thromboembolic events compared to the general population. Previous studies have shown that patients with sickle cell disease, who are also prone to ischemic events, have higher intracranial arterial blood flow velocities measured by transcranial Doppler sonography (TCD). The aim of this study is to evaluate intracra...

2014
Anat Aharon Annie Rebibo-Sabbah Inna Tzoran Carina Levin

Extracellular vesicles (EVs), comprised of exosomes, microparticles, apoptotic bodies, and other microvesicles, are shed from a variety of cells upon cell activation or apoptosis. EVs promote clot formation, mediate pro-inflammatory processes, transfer proteins and miRNA to cells, and induce cell signaling that regulates cell differentiation, proliferation, migration, invasion, and apoptosis. T...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید